![Frontiers | Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps Frontiers | Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps](https://www.frontiersin.org/files/MyHome%20Article%20Library/1137907/1137907_Thumb_400.jpg)
Frontiers | Considerations for shared decision-making in treatment of chronic rhinosinusitis with nasal polyps
![Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status - Fujieda - 2022 - Allergy - Wiley Online Library Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status - Fujieda - 2022 - Allergy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/f761867b-6812-4d31-b81e-62d9f76c300c/all14906-toc-0001-m.jpg?trick=1699081485996)
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status - Fujieda - 2022 - Allergy - Wiley Online Library
![Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine](https://www.thelancet.com/cms/attachment/a7069d04-3345-4ed5-b629-3544230e6d20/gr1_lrg.jpg)
Mepolizumab for chronic rhinosinusitis with nasal polyps (SYNAPSE): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Respiratory Medicine
![Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis - Bachert - 2020 - Allergy - Wiley Online Library Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis - Bachert - 2020 - Allergy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/fdc8cbc5-3c5c-4c50-92a8-78e9d1ab840a/all13984-fig-0003-m.jpg)
Dupilumab improves health‐related quality of life in patients with chronic rhinosinusitis with nasal polyposis - Bachert - 2020 - Allergy - Wiley Online Library
![Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status - Fujieda - 2022 - Allergy - Wiley Online Library Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status - Fujieda - 2022 - Allergy - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2b84dfb5-eec2-4cc5-b321-89f18e3b405a/all14906-fig-0001-m.jpg)
Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status - Fujieda - 2022 - Allergy - Wiley Online Library
Sanofi's Consumer Healthcare Division Chattem Announces Nasacort® Allergy 24HR Nasal Spray Now Available Without a Prescription in the U.S.
![Pharmacy | Free Full-Text | Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice Pharmacy | Free Full-Text | Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice](https://www.mdpi.com/pharmacy/pharmacy-08-00085/article_deploy/html/images/pharmacy-08-00085-g001.png)
Pharmacy | Free Full-Text | Managing Allergic Rhinitis in the Pharmacy: An ARIA Guide for Implementation in Practice
![Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study | American Journal of Psychiatry Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Combined With a Newly Initiated Oral Antidepressant in Treatment-Resistant Depression: A Randomized Double-Blind Active-Controlled Study | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/ajp.2019.176.issue-6/asset/16c05576-8b16-0557-58b1-c0557658b16c/ajp.2019.176.issue-6.cover.jpg)